Evidence map›Paper›PMID 29760755›Full record

ArticleIranian journal of pathology2017

Fluorescent in Situ Hybridization and Real-Time Quantitative Polymerase Chain Reaction to Evaluate

Fatemeh Homaei Shandiz, Azar Fani, Sepideh Shakeri, Maryam Sheikhi, Abouzar Ramezani Farkhani, Arezoo Shajiei, Hossein Ayatollahi

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Iranian journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fatemeh Homaei ShandizDept. of Radiation Oncology, Mashhad University of Medical Sciences, Cancer Research Center.
Azar FaniDept. of Radiation Oncology, Mashhad University of Medical Sciences, Cancer Research Center.
Sepideh ShakeriCancer Molecular pathology Research center, Ghaem Hospital, Mashhad university of Medical sciences, Mashhad, Iran.
Maryam SheikhiCancer Molecular pathology Research center, Ghaem Hospital, Mashhad university of Medical sciences, Mashhad, Iran.
Abouzar Ramezani FarkhaniDept. of New Sciences and Technology, Mashhad University of Medical Sciences, Mashhad, Iran.
Arezoo ShajieiCancer Molecular pathology Research center, Ghaem Hospital, Mashhad university of Medical sciences, Mashhad, Iran.
Hossein AyatollahiCancer Molecular pathology Research center, Ghaem Hospital, Mashhad university of Medical sciences, Mashhad, Iran.
Ghaem Hospital · IRMashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer remains the most common and second lethal cancer in females.

methodsFluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) methods are options to evaluate

resultsThe study investigated the performance of the real-time PCR as measured against FISH method in IHC +2 borderline cases. In a total of 120 IHC 2+ samples, 58.3% were negative and 41.6% positive for

conclusionDespite the fact that real-time PCR is a promising method to evaluate

Indexed as

Breast CancerGene QuantificationHER-2/neuQuantitative Real-Time PCR

Identifiers

PMID29760755
PMCPMC5938726
OpenAlexW2596502251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.